Cellevate Inc.
Transforming Biomanufacturing Through Nanofiber Technology Cellevat3d® VAX microcarriers redefine viral vaccine production with >10-fold higher yields
Funding history
About Cellevate Inc.
How much funding has Cellevate Inc. raised?
Cellevate Inc. has raised $25K in total funding. The most recent round was Seed.
Where is Cellevate Inc. headquartered?
Cellevate Inc. is headquartered in Long Beach, CA.
What does Cellevate Inc. do?
Transforming Biomanufacturing Through Nanofiber Technology Cellevat3d® VAX microcarriers redefine viral vaccine production with >10-fold higher yields
What problem does Cellevate Inc. solve?
Conventional cell culture microcarriers limit yield and drive up cost and complexity in biopharmaceutical production of viral vaccines, vectors, and cell/gene therapies.
What's Cellevate Inc.'s solution?
Cellevate offers Cellevat3d, a proprietary nanofiber-based microcarrier technology for upstream bioprocessing that scales from R&D to commercial production.
What makes Cellevate Inc. different?
The company cites over 10-fold higher viral vaccine yields versus current solutions, up to 85% lower production costs, a biodegradable cellulose-based material, and ISO 9001:2015 certification with GMP clean-room manufacturing.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.